[Old drugs and new approval procedures: Akrinor remains marketable and an application for reapproval of Arginin Vasopressin has been made].
Koch
T
T
Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Carl Gustav Carus, Technische Universität, Fetscherstrasse 74, 01307 Dresden. thea.koch@uniklinikum-dresden.de
Wenzel
V
V
D001127:Arginine Vasopressin / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003422:Critical Care; D017277:Drug Approval; D004338:Drug Combinations; D004345:Drug Industry; D005858:Germany; D006801:Humans; D013806:Theophylline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D002317:Cardiovascular Agents; D004338:Drug Combinations; D014662:Vasoconstrictor Agents; D001127:Arginine Vasopressin; C000147:cafedrine, theodrenaline drug combination; D013806:Theophylline